AKORN FDA Approval ANDA 206719

ANDA 206719

AKORN

FDA Drug Application

Application #206719

Application Sponsors

ANDA 206719AKORN

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION50,000 UNITS/VIAL0BACITRACINBACITRACIN

FDA Submissions

UNKNOWN; ORIG1AP2017-10-20STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206719
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"BACITRACIN","activeIngredients":"BACITRACIN","strength":"50,000 UNITS\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/20\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-10-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.